eTheRNA Immunotherapies is a startup based in Belgium, 1 tracked investor.
Based in Belgium, eTheRNA Immunotherapies is a startup. Brouky records 1 investor associated with the company.
eTheRNA Immunotherapies is a clinical-stage biotechnology company developing mRNA-based immunotherapies for cancer. Its TriMix platform combines three mRNAs (caTLR4, CD40L and CD70) to activate dendritic cells and induce antigen-specific T-cell responses against tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.